LY-2300559 is a metabotropic glutamate receptor 2 (mGluR2) agonist potentially for the treatment of migraine References: Polster CS, Wu SJ, Gueorguieva I, Sperry DC. Mechanism for enhanced absorption of a solid dispersion formulation of LY2300559 using the artificial stomach duodenum model. Mol Pharm. 2015 Apr 6;12(4):1131-40. doi: 10.1021/mp5006036. PubMed PMID: 25723790.

纯度：≥98%

CAS：889116-06-7